Facility Collaborations

Collaborations with Biotech/Pharma - Past 5 Years

Pfizer/iTeos Therapeutics, Gosselies, Belgium
Immunotherapy for Breast Cancer Metastasis to Brain

Synta Pharmaceuticals, Lexington, MA
Targeting Hsp90 for Treatment of Breast Cancer

Pfizer Research Technology Center, Cambridge, MA
Gene Targeting Using Viral Vectors for Cancer Diagnosis and Treatment

Gilead Sciences, Seattle, WA
Targeting Tumor Induced Immunosuppression Mechanisms for Breast Cancer Treatment: Effects of Therapeutics on Primary Tumor Growth, Metastasis and Immune Suppressor Cell Populations

Wyss Institute, Cambridge, MA
Novel Approaches for Antigen-induced Immune Stimulation for Treatment of Melanoma: Labeling and Pharmacokinetic Analysis of Scaffold-bound CpG Oligonucleotide

Tokai Pharmaceuticals, Cambridge, MA
Targeting Androgen Receptor for Treatment of Breast Cancer

Merrimack Pharmaceuticals, Cambridge, MA
Liposome Targeting for Treatment of Breast Cancer

On Dot Target Molecules, Atlanta, GA
Antibody-Targeted Radiofrequency Ablation for Cancer Treatment

NIH Chemical Genomics Center, Rockville, MD
Targeting the Perinucleolar Compartment (PNC) for Treatment of Prostate Cancer: Therapeutic Safety and Effects of PNC Inhibitors on Primary Prostate Tumor Growth and Metastasis

Arisaph Pharmaceuticals, Boston, MA
Novel FAP-activated Therapeutics for Treatment of Breast Cancer: Effects of Proprietary Agents on Mammary Tumor Growth and Metastasis

Aura Biosciences, Cambridge, MA
Targeting Tumor Cells Using HPV-based Nanoparticles: Can HPV-based Nanoparticles Be Used to Target Mammary Tumor Cells at Primary and Metastatic Sites?

Polyphor Ltd., Allschwil, Switzerland
Effects of CXCR4 antagonists on Mammary Tumor Growth and Metastasis

Jovesis Therapeutics, Napa, CA
Targeting Tumor-associated Macrophages for Treatment of Breast Cancer: Formulation Development, Therapeutic Safety and Effects of Inhibitors on Mammary Tumor Growth and Metastasis

Academic Collaborations - Past 5 Years

Elazer Edelman Laboratory, Harvard-MIT Division of Health Sciences and Technology, Biomedical Engineering Center, Cambridge, MA
Tracking Erosion of Biodegradable Materials in Vivo Using Luminescence Imaging

Daniel Jay Laboratory, Tufts University School of Medicine, Boston, MA
Identification of CD44 as a surface biomarker for drug resistance by surface proteome signature technology

Art Tischler Laboratory, Tufts Medical Center, Boston, MA
Novel Preclinical Testing Strategies for Treatment of Metastatic Pheochromocytoma

Krishna Kumar Laboratory, Chemistry, Tufts University, Medford, MA
Use of Fluorinated Cell Surfaces to Modulate Biological Function in Breast Cancer

William Bachovchin Laboratory, Tufts University School of Medicine, Boston, MA
Serine Protease-based Approaches for Diagnosis and Treatment of Cancer

Theoharis Theoharides Laboratory, Tufts University School of Medicine, Boston, MA
Stimulatory Effect of Stress on Breast Cancer Metastasis to Brain

Michael Forgac Laboratory, Tufts University School of Medicine, Boston, MA
Involvement of V-ATPase in Breast Cancer Invasion